BioTrinity cemented it's position as Europe’s leading investment and biopartnering conference once again by attracting 1020 executives from R&D, global pharma and investor companies across the life sciences industry to achieve their business objectives; to secure funding, seek acquisition and in-licensing deals and grow their network.
The packed conference kicked-off with a keynote from the first Minister for Life Sciences, George Freeman MP who set out his 'Manifesto for Health and Life Sciences in the UK', highlighting the strengths and future challenges for the health and life sciences sectors in the UK, on behalf of the UK Government.
Delegates from all corners of the world worked through their tailored schedules to hear expert advice from the industry influencers on panels, meet future partners and investors and attend their choice of the many networking events. Exhibitors introduced many, many delegates to their products and services and companies reaped the benefits of raising their profile through company showcases.
The aim is that every year BioTrinity offers: